Sterling Biotech Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Sterling Biotech Ltd. on BSE

Search Inside the pdf :

Sterling Biotech Ltd.

14 Nov 2022

Company Update

STERLING BIOTECH LTD. - 512299 - Intimation Of Liquidation Process As Per The Requirement Of Regulation …

BSE India

Intimation of Liquidation Process as per the requirement of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Details in uploaded File.

pdf

Sterling Biotech Ltd.

14 Nov 2022

Company Update

STERLING BIOTECH LTD. - 512299 - Intimation Of Liquidation Process As Per The Requirement Of Regulation …

BSE India

pdf

Sterling Biotech Ltd.

04 Nov 2022

Company Update

STERLING BIOTECH LTD. - 512299 - Statement Of Investor Complaints For The Quarter Ended September 2022

BSE India

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0220 Name of the Signatory :- Dr hc Adv Mamta Binani Liquidator of SBLDesignation :- Chief Executive Officer

Sterling Biotech Ltd.

12 Oct 2022

Result

STERLING BIOTECH LTD. - 512299 - Audited Financial Statement For The Financial Year 2021-22

BSE India

Please find attached herewith Audited Financial Statement for the financial year 2021-22 of Sterling Biotech Limited along with Auditors Report.

pdf

Sterling Biotech Ltd.

20 Jul 2022, 05:04PM

Company Update

STERLING BIOTECH LTD. - 512299 - Statement Of Investor Complaints For The Quarter Ended June 2022

BSE India

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Dr hc Adv Mamta Binani Liquidator of SBLDesignation :- Chief Executive Officer

Sterling Biotech Ltd.

29 Apr 2022

Corp. Note

STERLING BIOTECH LTD. - 512299 - Format of the Initial Disclosure to be made by an …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompaySTERLING BIOTECH LTD. 2CINL51900MH1985PLC035738 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 2280.49 4Highest Credit Rating during the previous FY 0 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: No Designation: No EmailId: sterlingbiotech@stergel.com Name of the Chief Financial Officer: No Designation: No EmailId: sterlingbiotech@stergel.com Date: 29/04/2022 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

Sterling Biotech Ltd.

22 Apr 2022

Company Update

STERLING BIOTECH LTD. - 512299 - Intimation Of Liquidation Process As Per The Requirement Of Regulation …

BSE India

pdf

Sterling Biotech Ltd.

21 Apr 2022, 01:15PM

Company Update

STERLING BIOTECH LTD. - 512299 - Certificate From Practicing Company Secretary For The Year Ended March …

BSE India

Dear Sir/Madam, With reference to the subject matter, enclosing herewith please find the Certificate from Practicing Company Secretary for the year ended March 31, 2022 as required under Regulation 40(10) of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, as amended from time to time. You are requested to take the same on records and oblige. Thanking You.

pdf

Sterling Biotech Ltd.

21 Apr 2022, 01:10PM

Company Update

STERLING BIOTECH LTD. - 512299 - Compliance Certificate As On March 31, 2022 Under Regulation 7(3) …

BSE India

Dear Sir/Madam, With reference to the subject matter, please find enclosed herewith the Compliance Certificate as on March 31, 2022 as required under Regulation 7(3) of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015. You are requested to take the same on records and oblige. Thanking You.

pdf

Sterling Biotech Ltd.

21 Apr 2022, 12:06PM

Company Update

STERLING BIOTECH LTD. - 512299 - Statement Of Investor Complaints For The Quarter Ended March 2022

BSE India

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Dr hc Adv Mamta Binani Liquidator of SBLDesignation :- Chief Executive Officer

Is Sterling Biotech Ltd. worth buying?

17 Votes:

Buy 58.82%

Sell 17.65%

Hold 23.53%

RESEARCH REPORTS

Sterling Biotech Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Sterling Biotech Ltd. on BSE

No research report for Sterling Biotech Ltd.